Bay Area laboratory solutions company Agilent Technologies has agreed to acquire Biocare Medical, a pathology solutions business, in an all-cash transaction valued at $950 million. Agilent aims to ...

Citi is positioning selectively across life sciences by favoring recovery names with clear catalysts while avoiding companies navigating accounting uncertainty, with Agilent’s pending Biocare deal ...

Agilent Technologies acquires Biocare Medical for $950M to expand into high-growth pathology and cancer diagnostics, enhancing recurring consumables revenue streams. Agilent trades below historical ...

March 9 (Reuters) - Life sciences firm Agilent Technologies (A.N), opens new tab said on Monday that it will acquire privately held clinical pathology firm Biocare Medical in an all-cash ‌deal valued ...

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...

Agilent Technologies Inc. agreed to acquire privately held Biocare Medical, which makes instruments and materials used in cancer research, in an all-cash transaction valued at $950 million. Biocare ...

Expands Agilent’s pathology portfolio through addition of highly complementary antibody, reagent and instrument business with annual double-digit revenue and profit growth since 2021 Expected to be ...

Life sciences tools company Agilent Technologies (NYSE:A) will be reporting earnings this Wednesday afternoon. Here’s what you need to know. Agilent beat analysts’ revenue expectations last quarter, ...

Agilent Technologies is a broad-based life science and analytical instrument company with a product portfolio spanning chromatography (GC/LC), mass spectrometry, spectroscopy, lab automation, vacuum ...

Agilent Technologies President and CEO Padraig McDonnell joins 'Mad Money' host Jim Cramer to talk quarterly results, where it is seeing growth opportunities, the type of research it is supporting and ...

Agilent Technologies reported its fourth-quarter 2025 earnings, surpassing expectations with earnings per share (EPS) of $1.59 compared to a forecast of $1.58. The company’s revenue reached $1.86 ...